Skip to main content
. 2016 Jul 8;6(7):e442. doi: 10.1038/bcj.2016.51

Table 2. Univariate and multivariate analysis of leukemia-free survival (LFS) and overall survival (OS).

  LFS
  OS
  P-value Hazard ratio 95% CI
P-value Hazard ratio 95% CI
      Lower Upper     Lower Upper
Univariate analysis
 Male gender 0.977 0.99 0.59 1.67 0.448 1.27 0.68 2.38
 Age ⩾40 years 0.807 1.07 0.63 1.80 0.013 2.31 1.20 4.48
 WCC ⩾100 × 109/l 0.557 1.54 0.37 6.42 0.010 5.04 1.46 17.37
 BM blasts ⩾70% 0.762 0.91 0.48 1.72 0.010 2.43 1.23 4.79
 >1 induction to CR1 0.584 0.82 0.40 1.68 0.299 1.50 0.70 3.21
 HSCT at CR1 0.006 0.28 0.11 0.70 0.246 0.60 0.25 1.43
 Mutations in signaling 0.020 3.42 1.22 9.63 0.047 4.26 1.02 17.80
 Mutations in methylation 0.030 2.26 1.08 4.72 0.940 0.96 0.37 2.50
KIT-AL 0.004 2.46 1.33 4.55 0.001 3.09 1.56 6.12
TET2 0.019 2.64 1.17 5.97 0.996 1.00 0.35 2.85
RAS 0.785 0.91 0.45 1.84 0.804 0.90 0.41 2.00
FLT3 0.664 0.80 0.28 2.23 0.966 0.98 0.30 3.19
RAD21 0.284 0.57 0.20 1.60 0.406 0.61 0.18 1.98
KIT-ALNeg and TET2Neg 0.001 0.35 0.19 0.65 0.015 0.43 0.22 0.85
                 
Multivariate analysis
 Age ⩾40 years 0.013 2.36 1.19 4.65
 WCC ⩾100 × 109/l 0.109 2.90 0.79 10.65
 BM blasts ⩾70% 0.036 2.16 1.05 4.44
KIT-AL 0.001 2.84 1.50 5.36
TET2 0.004 3.43 1.48 7.96

Abbreviations: AL, activation loop; BM, bone marrow; CI, confidence interval; CR1, first complete remission; HSCT, hematopoietic stem cell transplantation; WCC, white cell count.

KIT-ALNeg and TET2Neg was not entered into multivariate analysis, as it would mutually exclude KIT-AL and TET2. Parameters showing statistical significance are highlighted in bold.